Articles by Disease (Scleroderma)

Iontophoresis - An Approach for Controlled Drug Delivery: A Review

Journal: Current Drug Delivery
Volume: 4
Page: 1-10
Author(s): Nitin Dixit, Vikas Bali, Sanjula Baboota, Alka Ahuja and Javed Ali

Relaxin Receptors - New Drug Targets for Multiple Disease States

Journal: Current Drug Targets
Volume: 8
Page: 91-104
Author(s): E. T. Van Der Westhuizen, R. J. Summers, M. L. Halls, R. A. D. Bathgate and P. M. Sexton

Subject Index To Volume 12

Journal: Current Pharmaceutical Design
Volume: 13
Page: xlviii-xlviii
Author(s): Bentham Science Publisher

Interest of α2-Adrenergic Agonists and Antagonists in Clinical Practice: Background, Facts and Perspectives

Journal: Current Topics in Medicinal Chemistry
Volume: 7
Page: 187-194
Author(s): Pierre-Antoine Crassous, Colette Denis, Herve Paris and Jean Michel Senard

Essential Fatty Acids - A Review

Journal: Current Pharmaceutical Biotechnology
Volume: 7
Page: 467-482
Author(s): Undurti N. Das

Viral Anti-Inflammatory Reagents: The Potential for Treatment of Arthritic and Vasculitic Disorders

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 6
Page: 331-343
Author(s): G. Munuswamy-Ramanujam, K. A. Khan and A. R. Lucas

Therapeutic Targeting of B Lymphocyte Stimulator (BLyS) in the Rheumatic Diseases

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 6
Page: 351-358
Author(s): William Stohl

NF-κ B and Rheumatic Diseases

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 6
Page: 359-372
Author(s): Takashi Okamoto

Targeting Fibrosis in Systemic Sclerosis

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 6
Page: 395-400
Author(s): Robert Lafyatis

Targeting Vascular Disease in Systemic Sclerosis

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 6
Page: 401-407
Author(s): Otylia Kowal-Bielecka